ASX Small Cap Lunch Wrap: Small caps flat as broader market advances
Link copied to
Small caps are underperforming this morning, dipping marginally as the rest of the market moves forward.
The Small Ordinaries index was down 0.6 points, or 0.02 per cent, while the ASX200 was up 0.4 per cent and the All Ordinaries up 0.34 per cent.
Sectors were mixed with health care, financials, tech, and property down and the other seven sectors up.
Materials were the biggest gainers, up 2.1 per cent, buoyed by BHP (ASX:BHP) and the gold miners, which were up sharply as the price of the precious metal rose 1.2 per cent.
The Reserve Bank of Australia is largely expected to keep the cash rate at an ultra-low 0.1 per cent in a decision to be handed down at 2.30pm AEST.
Here are the best performing ASX stocks this morning:
Swipe or scroll to reveal the full table. Click headings to sort. Highlighted stocks have released announcements.
Eve Investments (ASX:EVE) advanced 16.7 per cent to 0.7c after receiving its first organic honey order from Whole Foods Market, the upscale US supermarket chain owned by Amazon.com.
Medibio (ASX:MEB) was up 14.3 per cent to 0.8c after being awarded a US patent for its method of assessing the mental state of a subject through heartbeat data samples.
Microequities (ASX:MAM) was up 9.8 per cent to 61.5c after the microcap fund manager advised that “a frenzy of takeover activity and several bidding wars” within its open-ended investment funds had led to strong investment performance and thus large performance fees.
Here are the worst-performing ASX stocks this morning:
Swipe or scroll to reveal the full table. Click headings to sort.
Amplia Therapeutics (ASX:ATX) dropped 8.8 per cent to 26c after announcing a $3.8 million share placement at 23c a share.